News

argenx to Host Mid-Year Financial Call and Business Update

argenx to Host Mid-Year Financial Call and Business Update

Overview of the Upcoming Financial Results

argenx is set to outline its financial accomplishments from the first half of 2025 alongside a strategic business update during a scheduled conference call on July 31, 2025. The call is intended to provide investors and stakeholders with insights into the company’s operational progress and financial metrics.

Event Details

The financial results call will take place at 2:30 p.m. CET (8:30 a.m. ET) on July 31. During this call, the management team will share key updates, focusing on the advancements made in addressing severe autoimmune diseases through innovative therapies.

How to Access the Call

Participants can access the live call via a webcast available on argenx’s official website. For those unable to listen live, a replay of the call will remain accessible for approximately one year, ensuring that all interested parties can review the information shared.

Dial-in Information

If you prefer to attend the call via telephone, argenx has provided the following dial-in numbers:

Belgium: 32 800 50 201
France: 33 800 943355
Netherlands: 31 20 795 1090
United Kingdom: 44 800 358 0970
United States: 1 888 415 4250
Japan: 81 3 4578 9081
Switzerland: 41 43 210 11 32

Access Code

To join the conference call, please use the access code 3810049 and dial in 15 minutes prior to the start of the event.

About argenx and Its Commitment

As a leader in the immunology sector, argenx strives to transform the lives of individuals affected by severe autoimmune diseases. Collaborating with top-tier academic institutions through their Immunology Innovation Program (IIP), argenx is dedicated to developing novel antibody-based therapies that address critical medical needs.

Innovative Therapies

One of argenx's notable achievements includes the commercialization of the first approved neonatal Fc receptor (FcRn) blocker. This groundbreaking therapy shows promise for use in multiple serious autoimmune diseases while the company simultaneously pushes forward with various experimental treatments currently in development.

Staying Updated with argenx

For the latest updates, stakeholders are encouraged to visit argenx's website and follow their journey on various social media platforms. Staying connected allows interested parties to engage with the company’s latest advancements and news.

Contact Information

For media inquiries, please reach out to:

Media Contact:
Ben Petok
bpetok@argenx.com

For investor relations, contact:

Investor Contact:
Alexandra Roy
aroy@argenx.com

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The call aims to discuss argenx's half year 2025 financial results along with business updates.

How can I access the live webcast?

The live call will be available on argenx's Investors section of their website.

Is there a way to attend the call via phone?

Yes, dial-in numbers for various countries are provided to allow phone access to the call.

What achievements has argenx made in its therapies?

Argentx has pioneered the development of the first neonatal Fc receptor blocker and continues to evaluate its effectiveness across several autoimmune diseases.

How do I get more information about argenx?

Visit argenx's official website and follow them on social media for ongoing updates and information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 3

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 2

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
VEVOR's Labor Day Salute to Home DIY Warriors

Updated Category News Views 1

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Continue Reading
Consumer365 Lauds Happy Head's Custom Hair Treatments

Updated Category News Views 6

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 1

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Unlocking Insights: South Chicagoland Home Inspections

Updated Category News Views 0

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 2

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading

Top 5 Most Recently Viewed Articles

Celsius Holdings Faces Legal Challenges—What Investors Should Know

Updated Category News Views 365

Understanding the Recent Class Action Lawsuit Against Celsius Holdings Recently, Celsius Holdings, Inc. (NASDAQ: CELH) has found itself at the center of a significant legal challenge. This class action lawsuit, filed by a prominent law firm, seeks to address serious allegations involving the company's financial disclosures and dealings with PepsiCo, Inc. The Accusations...

Continue Reading
Five Star Bancorp Announces Next Cash Dividend for Shareholders

Updated Category News Views 138

Five Star Bancorp's Dividend Announcement Five Star Bancorp (Nasdaq: FSBC) is pleased to share exciting news regarding its latest shareholder return strategy. The company has declared a cash dividend amounting to $0.20 per share on its voting common stock. This marks a continuing commitment to delivering value to its shareholders and is a pivotal part of the firm’s...

Continue Reading
Enovix Shares Decline as Q3 Report Shifts Market Sentiment

Updated Category News Views 151

Enovix Experiences Stock Decline Post Q3 Report Enovix Corporation (NASDAQ: ENVX) is facing a significant drop in its stock price as investors react to its recent third-quarter financial results. The company reported quarterly losses and provided guidance for the upcoming quarter that did not meet market expectations, leading to a decline in share value. Details of the...

Continue Reading
Borregaard ASA Launches Strategic Share Repurchase Program

Updated Category News Views 129

Borregaard ASA Announces Share Repurchase Initiative Borregaard ASA, known by the ticker OSE: BRG, is set to execute a strategic share repurchase program aiming to enhance shareholder value. This initiative involves the buyback of up to 200,000 shares of the company’s outstanding common stock. Purpose of the Share Repurchase Program The primary goal of this repurchase...

Continue Reading
Forian Expands Influence with Acquisition of Kyber Data Science

Updated Category News Views 103

Forian's Strategic Move to Acquire Kyber Data Science Forian Inc. (Nasdaq: FORA), a prominent data science company, is making headlines with its recent acquisition of Kyber Data Science LLC. This move is set to enhance Forian's capabilities in the healthcare analytics arena while also enabling the company to expand into the financial services sector. Kyber Data Science: A...

Continue Reading